
Sangami Pugazenthi Awarded 2023 ABTA Lucien Rubinstein Award for ‘Radiation Resistance in Grade 2 Meningiomas’
Sangami Pugazenthi is rewarded for her research exploring biological processes behind radiation resistance in grade 2 meningiomas.
Want to join the ABTA virtual 50 mile Facebook Challenge? Check it out here.
Sign up for our bi-monthly email to get the latest news on treatments, support, and stories from the brain tumor community.
Sangami Pugazenthi is rewarded for her research exploring biological processes behind radiation resistance in grade 2 meningiomas.
The need for better brain tumor treatments and more help for patients is greater than ever. Brain tumors are still very hard to treat because of something called the blood-brain barrier, which makes it tough for medicine to reach the tumor. Brain tumor patients need more options.
That’s why we’re meeting hope head on—because donations lead to research, research leads to better treatments, and better treatments bring us closer to a cure.